The move demonstrates company’s commitment to rapid growth and innovation

January 12, 2016

Rockville, Md. — DrFirst, a leading provider of e-prescribing and secure texting solutions for healthcare providers, announced today it has acquired the assets of, a mobile e-prescribing application for iOS and Android devices. The move follows a banner year of investment and growth at DrFirst, which raised $42M in financing in 2015, including $25 million in equity financing from Goldman Sachs.

“We are pleased to launch the new year with this exciting acquisition,” said G. Cameron Deemer, president of DrFirst. “As we head into 2016, we are committed to further expanding our footprint in key areas of our operations, including e-prescribing, medication management and care collaboration, particularly on mobile platforms. Our strong financial footing enables us to seize new opportunities that align with that mission, both domestically and abroad.”

DrFirst leads the e-prescribing market with Rcopia® and EPCS Gold(SM), legend drug and controlled substance electronic prescribing technologies, already in use by 330 electronic medical record systems, 1,000 hospitals and 20,000 medical practices nationwide.

About DrFirst

Named one of the fastest growing companies in North America, DrFirst pioneers electronic prescribing, medication management and secure care collaboration solutions that enhance the doctor-patient point of encounter, optimize provider access to patient information, inform the doctor’s clinical view of the patient and improve care delivery and clinical outcomes. Our growth is driven by a commitment to innovation, security and reliability across a wide array of services. We are proud of our track record of service to more than 330 EMR/EHR/HIS partners and an extensive network of providers, pharmacies, hospitals and post-acute care facilities. Connect with us on Twitter @DrFirst, or on LinkedIn at

DrFirst contact:
Stu Ballatt